# A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

> **NCT00190515** · PHASE3 · COMPLETED · sponsor: **Haruhiko Fukuda** · enrollment: 1101 (actual)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** 5FU+l-leucovorin
- **DRUG:** UFT+Leucovorin

## Key facts

- **NCT ID:** NCT00190515
- **Lead sponsor:** Haruhiko Fukuda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 1101 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190515, "A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00190515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*